Article
High-level clarithromycin resistance: a metabolic vulnerability exploited by bismuth in <i>Helicobacter pylori</i>
2026-05-01
Abstract excerpt
<h4>Background & Aims</h4> Clarithromycin (CLA) resistance severely compromises the efficacy of triple therapy (TT) against Helicobacter pylori ( H. pylori ). Bismuth-based regimens exhibit greater efficacy against CLA-resistant H. pylori than against strains resistant to other antibiotics, suggesting a resistance-specific vulnerability rather than broad antimicrobial activity. The mechanistic basis for this s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8ce1100-f652-5899-86f5-9d661f888892
- DOI
- 10.64898/2026.04.29.26351907
